美国司法部周四表示，将把围绕堕胎药丸的斗争诉诸最高法院在上诉法院做出限制访问的裁决后到广泛使用的避孕药米非司酮。
上诉法院裁决;裁定将于周六早上生效。
“司法部强烈反对第五巡回法庭在希波克拉底医学联盟诉食品和药物管理局一案中做出的部分驳回我们在上诉期间暂缓执行的请求的裁决。我们将向最高法院寻求紧急救济，以捍卫FDA的科学判断，保护美国人获得安全有效的生殖保健，”司法部长梅里克·加兰在一份声明中说。
周三晚些时候，联邦上诉法院部分阻止了得克萨斯州一名联邦法官上周做出的前所未有的裁决，该裁决将推翻食品药品监督管理局对米非司酮的批准。
上诉法院批准了司法部的紧急请求，搁置美国地区法官Matthew Kacsmaryk在2000年暂停FDA对米非司酮的初始授权的决定，引用了诉讼时效。
2023年4月12日，在白宫罗斯福厅，司法部长梅里克·加兰在与生殖保健服务工作组的会议上发表讲话。
埃文·伍奇/美联社
然而，由三名法官组成的陪审团决定，Kacsmaryk裁决的其他部分仍然可以在周五结束时生效，该裁决暂停了FDA后来对米非司酮的批准使用所做的改变，并停止了该药物的邮寄销售。
对米非司酮获得FDA批准的挑战源于2022年11月在德克萨斯州阿马里洛提起的诉讼，该诉讼由总部位于亚利桑那州的保守基督教法律倡导组织捍卫自由联盟提起，该组织致力于禁止堕胎。
该案件被分配给Kacsmaryk，他于2019年在前总统唐纳德·特朗普(Donald Trump)的领导下被任命为联邦法官目前阿马里洛分庭的唯一法官美国德克萨斯州北区地方法院。
周四早些时候，白宫新闻秘书郭佳欣·让-皮埃尔对随同乔·拜登总统出访爱尔兰的记者说，政府将继续这场斗争。
“我们将继续在法庭上斗争。我们相信法律站在我们这边，我们会胜利...我可以向美国人民保证，这是我们对妇女的承诺，对全国数百万妇女的承诺，也是对提供者的承诺，他们每天都在第一线工作，确保妇女能够为自己的身体做出决定。
Justice Department to take abortion pill fight to Supreme Court: Garland
The Justice Department on Thursday said it would take the fight over an abortion pill to the Supreme Courtafter an appeals court ruling that would restrict accessto the widely-used abortion pill mifepristone.
The appeals courtrulingwas set to take effect early Saturday morning.
"The Justice Department strongly disagrees with the Fifth Circuit's decision in Alliance for Hippocratic Medicine v. FDA to deny in part our request for a stay pending appeal. We will be seeking emergency relief from the Supreme Court to defend the FDA's scientific judgment and protect Americans' access to safe and effective reproductive care," Attorney General Merrick Garland said in a statement.
The federal appeals court late Wednesday partially blocked an unprecedented ruling by a single federal judge in Texas last week would reverse the Food and Drug Administration's approval of mifepristone.
The appeals court granted the Justice Department's emergency request to put on hold U.S. District Judge Matthew Kacsmaryk's decision to suspend the FDA's initial authorization of mifepristone back in 2000, citing the the statute of limitations.
However, the three-judge panel determined that other parts of Kacsmaryk's ruling, which suspends changes the FDA later made to mifepristone's approved use and halts distribution of the drug by mail, could still go into effect at the end of the day Friday.
The challenge to mifepristone's FDA approval stems from a lawsuit filed in Amarillo, Texas, in November 2022 by Alliance Defending Freedom, an Arizona-based conservative Christian legal advocacy group working to outlaw abortion.
The case was assigned to Kacsmaryk, who was appointed to the federal bench in 2019 under former President Donald Trump and iscurrently the sole judge seated in the Amarillo divisionof the U.S. District Court for the Northern District of Texas.
Speaking earlier Thursday to reporters traveling with President Joe Biden on his visit to Ireland, White House press secretary Karine Jean-Pierre said the administration would continue the fight.
"We are going to continue to fight in the courts. We believe that the law is on our side and we will prevail ... I can reassure the American people that that is our commitment to women, millions of women across the country, and also providers who are, who are, you know, at the frontlines, working every day to make sure that women are able to make decisions for themselves about their own body," she said.
